Scinovex
reviewTop 1% cited

Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010

Journal of Natural Products · 2012 · Vol. 75(3) · pp. 311–335
David NewmanGordon M. Cragg

Abstract

This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.

Microbial Natural Products and BiosynthesisMarine Sponges and Natural ProductsSynthetic Organic Chemistry MethodsNatural productNatural (archaeology)Product (mathematics)Drug discoveryCover (algebra)Computer scienceMedicineGeographyChemistryBioinformatics

MeSH terms

Biological ProductsPharmacologyResearchMolecular StructureDrug ApprovalCombinatorial Chemistry TechniquesHistory, 20th CenturyHistory, 21st Century
Citations
4,650
FWCI
408.64
field-weighted impact
References
126
Percentile
100%
vs. same field & year
Citations per year
Cited by
Bioactivity of Brazilian plant extracts on Oncopeltus fasciatus
International Journal of Fauna and Biological Studies · 2014 · 4 citations
Antiplasmodial potential of Avicennia marina (Forsk.) Vierh
International Journal of Mosquito Research · 2023 · 2 citations
Biologically Active Metabolites Synthesized by Microalgae
BioMed Research International · 2015 · 463 citations
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
International Journal of Molecular Sciences · 2018 · 1,180 citations
Natural Products as Sources of New Drugs from 1981 to 2014
Journal of Natural Products · 2016 · 5,787 citations
Natural Products As Sources for New Pesticides
Journal of Natural Products · 2012 · 622 citations
Related articles
The Role of Natural Product Chemistry in Drug Discovery
Journal of Natural Products · 2004 · 1,353 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.